Similar Items: Metabolic and Glycemic Effects of Orforglipron, a GLP‐1 Receptor Agonist, in Adults With or Without Diabetes: A Network Meta‐Analysis of Randomised Clinical Trials
- Hypoglycemia Reporting in GLP‐1RA Trials for Type 1 Diabetes: A Critical Gap That Needs To Be Addressed
- Mirtazapine for gastrointestinal side effects of glucagon-like peptide-1 receptor agonist therapy in older adults
- Long‐Term Glycemic and Metabolic Profiles Observed During Imeglimin Therapy in Japanese Patients With Type 2 Diabetes Mellitus
- Comparative Efficacy and Safety of Tirzepatide in Asian and Non‐Asian Adults With Obesity Without Diabetes: A Systematic Review and Meta‐Analysis
- Efficacy of Metformin in Prevention of Glucocorticoid‐Induced Hyperglycemia in Patients Without Diabetes: A Meta‐Analysis
- Prevalence and predictors of poor glycemic control in patients with type 2 diabetes mellitus attending Alexandria Main University Hospital